Trademark: 97819600
Word
NAMIDA
Status Date
Friday, December 1, 2023
Filing Date
Thursday, March 2, 2023
5 Diagnostic test kits consisting primarily of medical diagnostic immunoassays and complement diagnostic reagents for testing of human diseases, namely, breast cancer, for clinical medical testing and medical use
44 Providing medical screening services for cancer and inflammatory diseases, and psychological maladies; Medical screening; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical screening using protein biomarkers; Medical screening using RNA and DNA biomarkers; Medical screening service in the field of tear testing for breast health screening
42 Biotechnology research and development; Medical research and development; Scientific research and development; Medical and scientific research services in the field of diagnostic tests for cancer, inflammatory diseases, and psychological maladies; Medical laboratories
Mar 6, 2023
New Application Entered
Mar 22, 2023
New Application Office Supplied Data Entered
Nov 30, 2023
Assigned To Examiner
Mar 1, 2024
Application Extension To Response Period - Received
Apr 12, 2024
Teas Amendment Of Use Received
Apr 12, 2024
Teas Response To Office Action Received
Dec 1, 2023
Non-Final Action Written
Dec 1, 2023
Non-Final Action E-Mailed
Dec 1, 2023
Notification Of Non-Final Action E-Mailed
Mar 1, 2024
Application Extension Granted/Receipt Provided
Apr 12, 2024
Use Amendment Filed
Apr 12, 2024
Amendment To Use Processing Complete
Trademark Alertz updated from USPTO on 2030-01-24
